European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancer
Authors:
Open Access
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Cancer Epidemiology
- Vol. 39, S107-S119
Abstract
No abstract availableKeywords
Funding Information
- European Union (2011 53 05, 2010 53 04, 2007IARC01)
- the International Agency for Research on Cancer
This publication has 218 references indexed in Scilit:
- Spectrum of Cancer Risk Among US Solid Organ Transplant RecipientsJAMA, 2011
- Hormonal and reproductive factors in relation to melanoma in women: Current review and meta-analysisEuropean Journal of Cancer, 2011
- Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancerCancer Causes & Control, 2011
- Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior HysterectomyJAMA, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysisEuropean Journal of Cancer, 2010
- Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trialThe Lancet, 2009
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002